Hemolytic uremic syndrome after renal transplantation: Immunosuppressive therapy with rapamycin [4]

Nephron

Volumn 91, Issue 1, 2002, Pages 177-

  Heering, Peter ^a   Deppe, C E ^a   Farokhzad, F ^a   Helmchen, U ^a   Grabensee, B ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; GRAFT REJECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; CYTOMEGALOVIRUS INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; SIROLIMUS; TACROLIMUS;

EID: 18344375272     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057626     Document Type: Letter

References (4)

1. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in adults
2. A case of late onset CsA-induced hemolytic uremic syndrome resulting in renal graft loss
3. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation
4. De novo HUS postrenal transplant after CMV infection